Skip to main content
Premium Trial:

Request an Annual Quote

And Never Looked Back

Tim Hubbard is profiled over at The Scientist. The article recounts how he arrived at the Sanger Centre hoping to continue his protein structure prediction work, but got caught up in working on the human genome sequencing project. Hubbard's new focus evolved in to Ensembl and, as the article says, "catapulted Hubbard to the forefront of genome informatics."

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.